Frymoyer, Adam
Van Meurs, Krisa P.
Drover, David R.
Klawitter, Jelena
Christians, Uwe
Chock, Valerie Y.
Article History
Received: 30 June 2020
Revised: 10 August 2020
Accepted: 13 August 2020
First Online: 12 September 2020
Competing interests
: A.F. is a scientific consultant for Takeda Pharmaceuticals unrelated to this work. D.R.D. is a scientific consultant for Masimo Corporation and AbbVie Inc. unrelated to this work. The other authors have no conflicts of interest to disclose.
: Informed consent was obtained for patients in the prospective study. A waiver of consent was granted for the retrospective study.